Appropriate response to influenza a (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy

American Journal of Gastroenterology

Volumn 106, Issue 2, 2011, Pages 370-372

  Molnár, Tamás ^a   Farkas, Klaudia ^a   Jankovics, István ^b   Melles, Márta ^b   Nagy, Ferenc ^a   Szepes, Zoltán ^a   Wittmann, Tibor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; CLINICAL ARTICLE; CROHN DISEASE; FEMALE; HUMAN; INFLUENZA VIRUS A H1N1; LETTER; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS; VACCINATION;

HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79751487298     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.395     Document Type: Letter

References (7)

1. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immuno modulators and biologics. Inflamm Bowel Dis 2009; 15: 1410-6.
2. Lu Y, Jacobson DL, Ashworth LA et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009; 104: 444-53.
3. Frank AL, Puck J, Hughes BJ et al. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol 1980; 12: 426-32. (Pubitemid 10054038)
4. Del Porto F, Lagana B, Biselli R et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006; 24: 3217-23.
5. Holvast A, Huckriede A, Wilschut J et al. Safety and Efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65: 913-8.
6. Salemi S, Picchianti-Diamanti A, Germano V et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNF -blockers: safety and immunogenicity. Clin Immunol 2010; 134: 113-20.
7. Rahier JF, Ben-Horin S, Chowers Y et al. European evidence based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Crohn's Colitis 2009; doi: 10.1016/ j.crohns.2009.02.010 .